MW
ADPT icon

Milestone Wealth’s Adaptive Biotechnologies ADPT Stock Holding History

Milestone Wealth’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$67K Hold
9,379
– – 0.07% 91
2022
Q2 		$76K Hold
9,379
– – 0.08% 88
2022
Q1 		$263K Hold
9,379
– – 0.21% 53
2021
Q4 		$263K Buy
+9,379
New +$287K 0.21% 53

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $159M AUM 139.66% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Milestone Wealth's ADPT Position: Q3 2022 in Review

Milestone Wealth held its Adaptive Biotechnologies (ADPT) position steady in Q3 2022 at 9,379 shares worth $67K. The position accounts for 0.07% of the portfolio, ranked #91.

Milestone Wealth first reported a position in ADPT in Q4 2021 and has held it in 4 quarters since. The position peaked at $263K in Q1 2022. 226 funds tracked by Wall St. Rank hold ADPT as of Q3 2022.

  • Milestone Wealth held 9,379 shares of Adaptive Biotechnologies worth $67K as of Q3 2022.
  • Milestone Wealth left its Adaptive Biotechnologies share count unchanged in Q3 2022.
  • Adaptive Biotechnologies made up 0.07% of Milestone Wealth's portfolio in Q3 2022, its #91 holding.
  • Milestone Wealth first reported a position in Adaptive Biotechnologies in Q4 2021 and has held it in 4 quarters since.
  • Milestone Wealth's Adaptive Biotechnologies position peaked at $263K in Q1 2022.
  • 226 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2022.

Based on Milestone Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.